Current issues relating to drug safety especially with regard to the use of biomarkers: a meeting report and progress update.

@article{Rolan2007CurrentIR,
  title={Current issues relating to drug safety especially with regard to the use of biomarkers: a meeting report and progress update.},
  author={Paul Edward Rolan and Meindert Danhof and Donald R. Stanski and Carl C. Peck},
  journal={European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences},
  year={2007},
  volume={30 2},
  pages={107-12}
}
An expert group met in Leiden to review the state-of-the-art in detecting drug-related safety problems and to review the role of biomarkers and modelling techniques. It was clear that new drugs are not necessarily safer than old drugs, despite much larger clinical trial programs. Larger or longer clinical trials may be unfeasible and postmarketing… CONTINUE READING